UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1379-1389

2020

Volltextzugriff (PDF)

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

Seminars in liver disease, 2018-08, Vol.38 (3), p.181-192

2018

Volltextzugriff (PDF)

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

PLoS pathogens, 2017-05, Vol.13 (5), p.e1006373-e1006373

2017

Volltextzugriff (PDF)

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

The Journal of infectious diseases, 2022-05, Vol.225 (10), p.1688-1693

2022

Volltextzugriff (PDF)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Journal of the International AIDS Society, 2017, Vol.20 (1), p.22146-n/a

2017

Volltextzugriff (PDF)

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2021-07, Vol.73 (2), p.e485-e493

2021

Volltextzugriff (PDF)

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

PloS one, 2011-03, Vol.6 (3), p.e17781-e17781

2011

Volltextzugriff (PDF)

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

PloS one, 2022-05, Vol.17 (5), p.e0267853-e0267853

2022

Volltextzugriff (PDF)

Natural History and Management of Hepatitis C: Does Sex Play a Role?

The Journal of infectious diseases, 2014-07, Vol.209 (suppl 3), p.S81-S85

2014

Volltextzugriff (PDF)

Opportunistische Infektionen: Was gibt es Neues?

Deutsche medizinische Wochenschrift, 2018-12, Vol.143 (24), p.1755-1758

2018

Volltextzugriff (PDF)

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2429-2438

2012

Volltextzugriff (PDF)

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

Clinical infectious diseases, 2021-09, Vol.73 (5), p.e1222-e1227

2021

Volltextzugriff (PDF)

Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis?

Journal of hepatology, 2024-06

2024

Volltextzugriff (PDF)

HIV-related stigma within communities of gay men: a literature review

AIDS care, 2012-04, Vol.24 (4), p.405-412

2012

Volltextzugriff (PDF)

Beyond viral suppression of HIV - the new quality of life frontier

BMC medicine, 2016-06, Vol.14 (1), p.94-94, Article 94

2016

Volltextzugriff (PDF)

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

The Lancet (British edition), 2015-03, Vol.385 (9973), p.1098-1106

2015

Volltextzugriff (PDF)

Late HIV diagnosis: Where we stand and the way forward

HIV medicine, 2022-12, Vol.23 (11), p.1115-1117

2022

Volltextzugriff (PDF)

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118

2012

Volltextzugriff (PDF)

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Journal of hepatology, 2017-02, Vol.66 (2), p.282-287

2017

Volltextzugriff (PDF)

Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

Clinical infectious diseases, 2021-10, Vol.73 (8), p.1440-1451

2021

Volltextzugriff (PDF)

Advances in the treatment of HIV/HCV coinfection in adults

Expert opinion on pharmacotherapy, 2018-01, Vol.19 (1), p.49-64

2018

Volltextzugriff (PDF)

The way forward in HCV treatment - finding the right path

Nature reviews. Drug discovery, 2007-12, Vol.6 (12), p.991-1000

2007

Volltextzugriff (PDF)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

EClinicalMedicine, 2021-10, Vol.40, p.101116-101116, Article 101116

2021

Volltextzugriff (PDF)

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

AIDS (London), 2019-07, Vol.33 (9), p.1455-1465

2019

Volltextzugriff (PDF)

Late presentation of chronic viral hepatitis for medical care: a consensus definition

BMC medicine, 2017-05, Vol.15 (1), p.92-92, Article 92

2017

Volltextzugriff (PDF)

1 – 25 von 619

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(562)
Mit Volltextzugriff
(511)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

Natural History and Management of Hepatitis C: Does Sex Play a Role?

Opportunistische Infektionen: Was gibt es Neues?

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis?

HIV-related stigma within communities of gay men: a literature review

Beyond viral suppression of HIV - the new quality of life frontier

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Late HIV diagnosis: Where we stand and the way forward

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials

Advances in the treatment of HIV/HCV coinfection in adults

The way forward in HCV treatment - finding the right path

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Late presentation of chronic viral hepatitis for medical care: a consensus definition

Suchergebnisse filtern